Literature DB >> 21820033

Post-translational modification of the androgen receptor.

Daniel Gioeli1, Bryce M Paschal.   

Abstract

Regulation of the androgen receptor (AR) by its cognate ligand is well established, but how post-translational modification modulates AR activity is only emerging. The AR is subject to modification by phosphorylation, acetylation, methylation, SUMOylation, and ubiquitination. As several of the enzymes that modify the AR are altered in prostate cancer, defining the context and physiological effects of these modifications could provide insight into mechanisms that underpin human disease. Here, we review how post-translational modification contributes to AR function as a transcription factor with particular emphasis on phosphorylation and dephosphorylation mechanisms.
Copyright © 2011. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21820033     DOI: 10.1016/j.mce.2011.07.004

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  63 in total

1.  Androgen receptor exon 1 mutation causes androgen insensitivity by creating phosphorylation site and inhibiting melanoma antigen-A11 activation of NH2- and carboxyl-terminal interaction-dependent transactivation.

Authors:  William H Lagarde; Amanda J Blackwelder; John T Minges; Andrew T Hnat; Frank S French; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

Review 2.  The 5α-androstanedione pathway to dihydrotestosterone in castration-resistant prostate cancer.

Authors:  Nima Sharifi
Journal:  J Investig Med       Date:  2012-02       Impact factor: 2.895

3.  Inhibition of IGF-1R diminishes transcriptional activity of the androgen receptor and its constitutively active, C-terminally truncated counterparts Q640X and AR-V7.

Authors:  Friedemann Zengerling; Anca Azoitei; Alexander Herweg; Florian Jentzmik; Marcus V Cronauer
Journal:  World J Urol       Date:  2015-08-29       Impact factor: 4.226

4.  Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer.

Authors:  Joshua W Russo; Xiaming Liu; Huihui Ye; Carla Calagua; Sen Chen; Olga Voznesensky; James Condulis; Fen Ma; Mary-Ellen Taplin; David J Einstein; Steven P Balk; Shaoyong Chen
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

Review 5.  Molecular pathogenesis and progression of prostate cancer.

Authors:  Randy Schrecengost; Karen E Knudsen
Journal:  Semin Oncol       Date:  2013-06       Impact factor: 4.929

Review 6.  Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases.

Authors:  Vladimir N Uversky; Vrushank Davé; Lilia M Iakoucheva; Prerna Malaney; Steven J Metallo; Ravi Ramesh Pathak; Andreas C Joerger
Journal:  Chem Rev       Date:  2014-05-15       Impact factor: 60.622

7.  Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer.

Authors:  Minoru Kato; Carmen A Banuelos; Yusuke Imamura; Jacky K Leung; Daniel P Caley; Jun Wang; Nasrin R Mawji; Marianne D Sadar
Journal:  Clin Cancer Res       Date:  2015-12-28       Impact factor: 12.531

Review 8.  Androgen receptor phosphorylation: biological context and functional consequences.

Authors:  Yulia Koryakina; Huy Q Ta; Daniel Gioeli
Journal:  Endocr Relat Cancer       Date:  2014-01-14       Impact factor: 5.678

Review 9.  AR function in promoting metastatic prostate cancer.

Authors:  Michael A Augello; Robert B Den; Karen E Knudsen
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

10.  Aging impairs VEGF-mediated, androgen-dependent regulation of angiogenesis.

Authors:  Laura Lecce; Yuen Ting Lam; Laura A Lindsay; Sui Ching Yuen; Philippa J L Simpson; David J Handelsman; Martin K C Ng
Journal:  Mol Endocrinol       Date:  2014-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.